Lupin on Wednesday said it has received approval from the USFDA for Formoterol Fumarate Inhalation Solution, used in treating symptoms of chronic obstructive pulmonary disease.
The company has received approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of Mylan Specialty’s Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement.
As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market.
Shares of Lupin ended 2.55 per cent down at Rs 677.65 apiece on the BSE on Wednesday.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
To use your Blue Cross Blue Shield of Massachusetts insurance card, sign in to MyBlue,…
To activate your Venmo Credit Card, open the Venmo app, scan your card or follow…
To activate your PCH code, go to the official PCH website, enter the code carefully,…
To activate your Sears MasterCard, go to the official card website or call the number…
Bringing your own device to Verizon starts with checking compatibility, entering your phone’s IMEI, choosing…
Activating your Ace Flare Card online is quick. Go to the card website, enter your…